I
Integra LifeSciences
Integra LifeSciences | Medical Device Company - Medical Technologies
About Integra LifeSciences
In 1989, Richard Caruso founded Integra LifeSciences with a clear vision: to expand access to technology that helps the body regenerate damaged tissue. This idea laid the groundwork for a new field of medicine known as regenerative medicine. The company's journey began by licensing a promising 'artificial skin' technology developed at MIT and Harvard Medical School. This technology was designed to treat severe burn victims by providing a scaffold for new skin to grow. A pivotal moment came in 1995 when Integra LifeSciences went public on the NASDAQ, trading under the ticker IART. The following year, its flagship product, the Integra Artificial Skin, received FDA approval, marking the first commercially available tissue regeneration product. This breakthrough solidified the company's foundation and set it on a path of growth. Over the years, Integra expanded its portfolio through strategic acquisitions, moving into neurosurgery, specialty surgical instruments, and wound care. This strategy transformed Integra into a profitable and diversified medical technology company, committed to advancing standards of care in surgery and regenerative medicine.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1989
- Headquarters
- Plainsboro Township, United States
- Listing
- IPO 1995
- Employees
- 3,858
- Open positions
- 4
- Dealroom signal
- 34.6/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Biotechnology, Data Centers, observatoire healthtech
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 11 companies, latest Apr 2024
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Oct 2026 | $600M | — | Undisclosed | ↗ |
| POST IPO EQUITY✓Other financing | May 2018 | $350M | — | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Integra LifeSciences is 65K monthly website visits, up 51.2% over the last three months. Integra LifeSciences's team grew 1.6% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 WaivAI precision tests for oncology |
Paris, France | Operational | 52 | $35M | $140M |
 SysmexAutomated diagnostic solutions for medical laboratories |
Villepinte, France | Operational | |||
 RadiometerAcute care diagnostic testing solutions and analyzers |
Neuilly-Plaisance, France | Operational | |||
 RainPath AIIs revolutionizing human tissue analysis through AI, no chemical staining, faster, clearer, more reliable |
La Mézière, France | Operational | |||
 NeurometersResearch, development, and commercialization of medical devices |
France | Operational | |||
 LinkX RoboticsInnovative surgical robotics enhancing knee stability and reducing osteoarthritis pain |
Saint-Martin-d'Hères, France | Operational | |||
 SurgeInnovative fingerprinting of the immune system with AI to holistically improve the perioperative standard-of-care |
Paris, France | Operational | |||
 DyameoDyameo is a company specializing in in-vivo medical diagnosis |
Limoges, France | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
AcclarentMenlo Park, United StatesNew technologies to treat patients suffering from ent disorders
$278Mvaluation
SIA HealthChicago, United StatesSurgical Innovation Associates, Inc. (SIA) is now part of Integra LifeSciences, a leader in medical tech, innovating treatments to restore patients' lives
$50Mvaluation
ACellColumbia, United StatesAnd manufactures unique extra cellular matrix products to repair and remodel damaged tissues through remodeling
$300Mvaluation
RT
Rebound TherapeuticsIrvine, United StatesInnovative single-use devices enhancing minimally invasive neurosurgical procedures with advanced access, imaging, and illumination
→
Arkis BioSciencesKnoxville, United StatesMedical device company providing minimally invasive surgical instrumentation and advanced implantable technology
$18Mvaluation
Codman NeuroRaynham, United StatesGlobal neurosurgery and neurovascular company
$1Bvaluation
TGX Medical SystemsCarmel-by-the-Sea, United StatesAnd markets software solutions for medical asset management and tracking
$6Mvaluation
DS
Derma SciencesPrinceton, United StatesProviding a complete line of products for wound and skin care
$205Mvaluation
TM
Tarsus MedicalMenlo Park, United StatesSolutions and devices for unsolved problems within the field of podiatry
$4.7Mvaluation
AO
Ascension OrthopedicsAustin, United StatesOrthopedic implants for shoulder, elbow, wrist, and ankle
$65Mvaluation
IT
Innovative Spinal TechnologiesPlano, United StatesInnovative Spinal Technologies, a biotech company, develops motion preservation and minimally-invasive treatments for spinal disorders
$72Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Telegraph Hill Partners
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Integra LifeSciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Integra LifeSciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.